IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takashima, Y.
Right arrow Articles by Honda, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takashima, Y.
Right arrow Articles by Honda, Y.

Investigative Ophthalmology & Visual Science, Vol 37, 2671-2677, Copyright © 1996 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Ocular hypotensive mechanism of intravitreally injected brain natriuretic peptide in rabbit

Y Takashima, T Taniguchi, M Yoshida, MS Haque, N Yoshimura and Y Honda
Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Japan.

PURPOSE: To determine whether brain natriuretic peptide (BNP) affects intraocular pressure (IOP), aqueous humor dynamics, and cyclic guanosine monophosphate (cGMP) concentration in the aqueous humor of the rabbit eye. METHODS: Twenty microliters of 10(-4) M and 10(-5) M (2 nmol, 0.2 nmol) BNP or atrial natriuretic peptide (ANP) were injected intravitreally into rabbit eyes, after which the IOP was measured using a pneumatonometer. Aqueous humor dynamics were studied at approximately 6 hours after the intravitreal injection of 2 nmol BNP. Aqueous humor flow was measured by fluorophotometry, and outflow facility was measured by the two-level constant pressure perfusion method, whereas uveoscleral outflow was measured by the fluorescein isothiocyanate- dextran perfusion method. The concentration of cGMP in the aqueous humor at 6 hours after injection of 2 or 0.2 nmol BNP also was measured by enzyme immunoassay. RESULTS: Intravitreal administration of BNP or of ANP caused a decrease in IOP, with a maximum effect at approximately 6 hours after the injection. Total outflow facility in eyes treated with 2 nmol BNP increased by 29%, although the aqueous humor flow and uveoscleral outflow did not show significant changes. The concentration of cGMP in the aqueous humor increased significantly in BNP-treated eyes. CONCLUSIONS: Intravitreal injection of BNP into rabbit eyes reduced IOP because of an increase in the outflow facility. Brain natriuretic peptide also increased the concentration of cGMP in the aqueous humor. It is probable that BNP-activated guanylate cyclase induced an upregulation of cGMP in the aqueous humor.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
D. E. Potter, K. R. M. Russell, and M. Manhiani
Bremazocine Increases C-Type Natriuretic Peptide Levels in Aqueous Humor and Enhances Outflow Facility
J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 548 - 553.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. Honjo, M. Inatani, N. Kido, T. Sawamura, B. Y.-J. T. Yue, Y. Honda, and H. Tanihara
Effects of Protein Kinase Inhibitor, HA1077, on Intraocular Pressure and Outflow Facility in Rabbit Eyes
Arch Ophthalmol, August 1, 2001; 119(8): 1171 - 1178.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Association for Research in Vision and Ophthalmology